// App-Quantinova.ai

2604 : Chemoprevention of colorectal cancer by LFA-9, a novel dual mPGES-1/5-LOX inhibitor: safer approaches to chemoprevention

Researchers

Presenter

  • Naveena B. Janakiram

Principal Investigators

  • Altaf Mohammed

  • Gopal Pathuri

  • Venkateshwar Madka

  • Rebekah Ritchie

  • Taylor Bryant

  • Yuting Zhang

  • Qian Li

  • Stan Lightfoot

  • Hariprasad Gali

  • Steele E. Vernon

  • Chen S. Suen

  • Chinthalapally V. Rao

Medical Centers

  • University of Oklahoma Health Sciences Center, Oklahoma City, OK

  • Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Oklahoma City, OK.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Prostaglandin E2

  • Cyclooxygenase-1

  • Cyclooxygenase-2

  • Leukotrienes

Drug/Treatment

  • Prostaglandin

  • Azoxymethane

  • Dinoprostone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved